SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Celgene-CELG -- Ignore unavailable to you. Want to Upgrade?


To: Miljenko Zuanic who wrote (403)2/9/2000 2:16:00 PM
From: Cheryl Galt  Read Replies (2) | Respond to of 804
 
I hesitate to disturb this quiet thread, but I think your stock is going to close over $100 today.
The 5-day chart is a work of art -- such a gentle, steady line....
finance.yahoo.com

Also parking this:

Tue Feb 8 --- CELG Celgene Corporation Increases Size of Proposed Common Stock Offering

WARREN, N.J., Feb. 8 /PRNewswire/ -- Celgene Corporation (Nasdaq: CELG - news) today announced that it intends to amend its registration statement currently on file with the Securities and Exchange Commission to increase the size of its proposed common stock offering to 3,000,000 shares.

Of the shares, 2,484,000 shares will be sold by Celgene for its own account. The remaining 516,000 shares will be sold by John Hancock Life Insurance Company and its affiliates. Celgene will also grant to the underwriters an option to purchase an additional 450,000 shares of common stock to cover over-allotments. ...

A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. ...